By Will Hazell2015-07-24T12:53:00
Delays to the introduction of groundbreaking, cost effective hepatitis C drugs have occurred because of ‘budget constraint’, NHS England’s specialised commissioning director has indicated.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud